Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
An essential oils-based antimicrobial mouthwash formulation evaluated by researchers at the University of Santiago de Compostela for the treatment and prevention of gingivitis. The formulation typically consists of a combination of phenolic compounds, including thymol, eucalyptol, menthol, and methyl salicylate. It exerts its therapeutic effect by penetrating the oral biofilm and disrupting the cell walls and membranes of plaque-causing bacteria, thereby reducing bacterial vitality and biomass. In clinical trials conducted by the University, the mouthwash demonstrated significant antiplaque efficacy comparable to the gold standard 0.2% chlorhexidine, making it a viable long-term alternative for oral hygiene and gingivitis management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on essential oils mouthwash.